{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:57:58Z","timestamp":1740128278081,"version":"3.37.3"},"reference-count":28,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":40,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Paediatr"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1111\/apa.13081","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T08:10:53Z","timestamp":1434183053000},"page":"927-932","source":"Crossref","is-referenced-by-count":3,"title":["Infants born before 32\u00a0weeks of gestation or with respiratory disease are most likely to receive palivizumab in the Netherlands"],"prefix":"10.1111","volume":"104","author":[{"given":"Leanne M.A.","family":"Kool-Houweling","sequence":"first","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research; Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernie J.A.","family":"Penning-van Beest","sequence":"additional","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research; Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene D.","family":"Bezemer","sequence":"additional","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research; Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"van Lingen","sequence":"additional","affiliation":[{"name":"Department of Neonatology Isala Clinics; Princess Amalia Department of Pediatrics; Zwolle the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron M.C.","family":"Herings","sequence":"additional","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research; Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"10.1111\/apa.13081-BIB0001|apa13081-cit-0001","doi-asserted-by":"crossref","first-page":"e1453","DOI":"10.1542\/peds.2010-0507","article-title":"Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis","volume":"126","author":"Garcia","year":"2010","journal-title":"Pediatrics"},{"key":"10.1111\/apa.13081-BIB0002|apa13081-cit-0002","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/01.inf.0000108188.37237.48","article-title":"National disease burden of respiratory viruses detected in children by polymerase chain reaction","volume":"23","author":"Henrickson","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/apa.13081-BIB0003|apa13081-cit-0003","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/apa.13081-BIB0004|apa13081-cit-0004","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/apa.13081-BIB0005|apa13081-cit-0005","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00431-007-0418-y","article-title":"Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics","volume":"166","author":"Rossi","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1111\/apa.13081-BIB0006|apa13081-cit-0006","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(99)80040-3","article-title":"Respiratory syncytial virus infection","volume":"354","author":"Simoes","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/apa.13081-BIB0007|apa13081-cit-0007","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/INF.0000000000000535","article-title":"RSV-still more questions than answers","volume":"33","author":"Bont","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/apa.13081-BIB0008|apa13081-cit-0008","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.inf.0000053885.34703.84","article-title":"Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage","volume":"22","author":"Romero","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/apa.13081-BIB0009|apa13081-cit-0009","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1111\/apa.13081-BIB0010|apa13081-cit-0010","first-page":"33","article-title":"Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)","volume":"1","author":"Geskey","year":"2007","journal-title":"Biologics"},{"key":"10.1111\/apa.13081-BIB0011|apa13081-cit-0011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.clinthera.2008.03.014","article-title":"Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria","volume":"30","author":"Resch","year":"2008","journal-title":"Clin Ther"},{"key":"10.1111\/apa.13081-BIB0012|apa13081-cit-0012","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/INF.0b013e318235455b","article-title":"Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria","volume":"31","author":"Resch","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/apa.13081-BIB0013|apa13081-cit-0013","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3111\/13696998.2010.499749","article-title":"The cost effectiveness of palivizumab: a systematic review of the evidence","volume":"13","author":"Smart","year":"2010","journal-title":"J Med Econ"},{"key":"10.1111\/apa.13081-BIB0014|apa13081-cit-0014","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archpediatrics.2010.298","article-title":"Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications","volume":"165","author":"Hampp","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1111\/apa.13081-BIB0015|apa13081-cit-0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12360","article-title":"Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation","volume":"12","author":"Wang","year":"2008","journal-title":"Health Technol Assess"},{"key":"10.1111\/apa.13081-BIB0016|apa13081-cit-0016","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/adc.2008.155556","article-title":"Passive immunisation against respiratory syncytial virus: a cost-effectiveness analysis","volume":"95","author":"Rietveld","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1111\/apa.13081-BIB0017|apa13081-cit-0017","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1651-2227.2011.02426.x","article-title":"Decision-making under conditions of uncertainty-what can we learn from palivizumab?","volume":"100","author":"Burls","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1111\/apa.13081-BIB0018|apa13081-cit-0018","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jech.46.2.136","article-title":"Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts","volume":"46","author":"Herings","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"10.1111\/apa.13081-BIB0019|apa13081-cit-0019","first-page":"1886","article-title":"[Pharmaco-morbidity linking: a potential instrument for post-marketing surveillance]","volume":"134","author":"Stricker","year":"1990","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/apa.13081-BIB0020|apa13081-cit-0020","first-page":"1903","article-title":"[Pharmaco-morbidity linking: a pilot study of its technical possibilities in The Netherlands]","volume":"134","author":"Herings","year":"1990","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/apa.13081-BIB0021|apa13081-cit-0021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpeds.2012.12.014","article-title":"First year of life medication use and hospital admission rates: premature compared with term infants","volume":"163","author":"Houweling","year":"2013","journal-title":"J Pediatrics"},{"issue":"Suppl. 1","key":"10.1111\/apa.13081-BIB0022|apa13081-cit-0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1526-0542(09)70004-1","article-title":"The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus","volume":"10","author":"Welliver","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"10.1111\/apa.13081-BIB0023|apa13081-cit-0023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1191\/096228001680195157","article-title":"A review of adjusted estimators of attributable risk","volume":"10","author":"Benichou","year":"2001","journal-title":"Stat Methods Med Res"},{"key":"10.1111\/apa.13081-BIB0024|apa13081-cit-0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2431-9-56","article-title":"Incidence and risk factors of hospitalization for bronchiolitis in preterm children: a retrospective longitudinal study in Italy","volume":"9","author":"Pezzotti","year":"2009","journal-title":"BMC Pediatr"},{"key":"10.1111\/apa.13081-BIB0025|apa13081-cit-0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jpeds.2009.12.016","article-title":"Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida","volume":"156","author":"Hampp","year":"2010","journal-title":"J Pediatr"},{"key":"10.1111\/apa.13081-BIB0026|apa13081-cit-0026","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1542\/peds.112.6.1447","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections","volume":"112","author":"Meissner","year":"2003","journal-title":"Pediatrics"},{"key":"10.1111\/apa.13081-BIB0027|apa13081-cit-0027","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10096-008-0520-8","article-title":"Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35\u00a0weeks gestational age","volume":"27","author":"Carbonell-Estrany","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/apa.13081-BIB0028|apa13081-cit-0028","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.inf.0000136869.21397.6b","article-title":"Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35\u00a0weeks in Spain","volume":"23","author":"Figueras-Aloy","year":"2004","journal-title":"Pediatr Infect Dis J"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapa.13081","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:13:32Z","timestamp":1625433212000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apa.13081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1111\/apa.13081","relation":{},"ISSN":["0803-5253"],"issn-type":[{"type":"print","value":"0803-5253"}],"subject":[],"published":{"date-parts":[[2015,7,23]]}}}